Company Focus

Johnson & Johnson

Latest Johnson & Johnson News

World Hepatitis Day 2025 spotlights barriers to elimination
Pharmaceutical
World Hepatitis Day, marked each year on July 28, is shining a light on what GlobalData calls an “urgent need” for a renewed push to tackle viral hepatitis as mortality rises worldwide. The disease remains among the deadliest infectious threats, affecting more than 300 million people globally.   28 July 2025


Latest News & Features of interest to Johnson & Johnson

Latest Related Ones To Watch News

Last week, a US Food and Drug Administration (FDA) advisory committee (AdCom) voted against approval of Danish drugmaker Lundbeck and Japan-based Otsuka’s Rexulti for post-traumatic stress disorder. France’s Sanofi announced it is expanding its respiratory vaccines pipeline with an up to $1.6 billion acquisition of UK biotech Vicebio. French biotech Abivax released new Phase III data on its investigational ulcerative colitis candidate obefazimod that saw its shares nearly quadruple. Also of note was the latest setback for Sarepta’s Duchenne muscular dystrophy drug Elevidys, when the European Medicines human health committee, the CHMP, declined partner Roche’s accelerated approval of the drug.   27 July 2025

More in M&A >


Related Ones to Watch Companies

Reset all filters
Refine Search